Diabetes and Surgical Site Infection Risk After Abdominal Hysterectomy
Diabetes significantly increases the risk of surgical site infection after abdominal hysterectomy (approximately 1.5-2 fold increased risk), and perioperative blood glucose should be maintained between 100-180 mg/dL (5.6-10.0 mmol/L) using a basal-bolus insulin regimen to reduce this risk. 1
The Evidence on Diabetes as a Risk Factor
Diabetes is a well-established independent risk factor for surgical site infections following hysterectomy. The most recent meta-analyses demonstrate:
- Diabetes increases SSI risk by approximately 2-fold (OR 2.01,95% CI 1.46-2.77) in hysterectomy patients 2
- This risk is consistent across multiple studies, with ORs ranging from 1.57 to 1.82 3, 4
- Beyond infection, diabetes also increases risks of readmission (OR 1.59), renal failure (OR 3.88), and 5-year mortality (OR 4.43) 2
The mechanism is multifactorial: impaired immunity, delayed wound healing, and perioperative hyperglycemia all contribute to increased infection risk 5.
Perioperative Glycemic Management Strategy
Preoperative Optimization
Target HbA1c <8% (<64 mmol/L) for elective surgeries whenever possible 1. Poor glycemic control (higher HbA1c) is strongly associated with SSI development, with infected patients showing mean HbA1c of 8.4% versus 7.1% in non-infected patients 5.
Medication Management Before Surgery
Follow this specific timeline 1:
- SGLT2 inhibitors: Stop 3-4 days before surgery (FDA recommendation due to euglycemic DKA risk)
- Metformin: Hold on day of surgery
- Other oral agents: Hold morning of surgery
- Insulin adjustments:
- NPH insulin: Reduce to 50% of usual dose
- Long-acting basal analogs: Reduce to 75-80% of usual dose
Intraoperative and Immediate Postoperative Targets
Maintain blood glucose 100-180 mg/dL (5.6-10.0 mmol/L) within 4 hours of surgery and throughout the perioperative period 1. This target is supported by:
- The 2025 ADA Standards of Care 1
- Evidence showing perioperative hyperglycemia independently increases SSI risk (RR 1.89-2.17) 6
- Meta-analysis demonstrating tight glycemic control (4.44-6.67 mmol/L) significantly reduces SSI, respiratory infections, and overall complications 7
Insulin Regimen
Use a basal-bolus insulin approach for non-critically ill diabetic patients undergoing surgery 8. This has shown adequate glycemic control in clinical trials and is the standard of care 1.
For patients requiring IV insulin infusion, administer subcutaneous basal insulin 2-4 hours before stopping the IV infusion to prevent rebound hyperglycemia 1.
Critical Caveats
The Hypoglycemia Trade-off
While intensive glycemic control reduces SSI risk, it increases hypoglycemia risk 9. This is why the target range is 100-180 mg/dL rather than tighter control. Point-of-care glucose monitoring every 4-6 hours is essential - do not rely on CGM alone during surgery 1.
Other Modifiable Risk Factors to Address
Beyond glycemic control, address these factors that compound diabetes-related SSI risk:
- Smoking cessation (OR 1.76-1.9 for SSI) 3, 5
- Minimize operative time when possible (>2 hours increases risk, OR 1.59-2.4) 5, 4
- Optimize wound classification and surgical technique 5
- Ensure appropriate antibiotic prophylaxis timing 5
Surgical Approach Considerations
Abdominal hysterectomy carries higher SSI risk than vaginal approach (OR 4.17 vs 1.22) 3. In diabetic patients, consider minimally invasive approaches when feasible, though this must be balanced against oncologic and technical factors.
Practical Implementation
- Preoperatively: Check HbA1c; if >8%, consider delaying elective surgery for optimization when safe
- Day before surgery: Adjust medications per timeline above
- Day of surgery: Check glucose within 4 hours of incision; target 100-180 mg/dL
- Intraoperatively: Monitor glucose if procedure >2 hours
- Postoperatively: Continue basal-bolus insulin with glucose checks every 4-6 hours until oral intake resumes and glucose stable
The attributable fraction of SSI due to perioperative hyperglycemia exceeds 60% 6, making glycemic control one of the most impactful modifiable risk factors you can address in diabetic patients undergoing abdominal hysterectomy.